Expert Commentary
Expert Commentary
Should we rethink maternal monitoring of fetal movement through “kick counts”?
An age-old recommendation may be contributing to more harm than good
Expert Commentary
Are single-incision mini-slings the new gold standard for stress urinary incontinence?
Authors of a UK noninferiority multicenter randomized controlled trial determined single-incision mini-slings to be...
Expert Commentary
Should treatment be initiated for mild chronic hypertension in pregnancy to improve outcomes?
Yes, antihypertensive medication should be used to reach a goal blood pressure of <140/90 mm Hg in pregnant patients with mild...
From the Editor
Misoprostol: Clinical pharmacology in obstetrics and gynecology
The effect of misoprostol on uterine contraction is greatly influenced by the dose and route of administration
Oxytocin and...
Expert Commentary
What are the perinatal risks of SARS-CoV-2 infection in pregnancy?
Trauma-informed care means considering the influence of traumatic stress in every area of a child's life - physical health, relationships, culture...
Expert Commentary
Defending access to reproductive health care
If precedents set in Roe v Wade are overturned, ObGyns have several immediate and long-term challenges
...Expert Commentary
Can US “pattern recognition” of classic adnexal lesions reduce surgery, and even referrals for other imaging, in average-risk women?
This is not a new concept. Numerous studies1 have found that pattern recognition performed as well or better...
Expert Commentary
What placental mechanisms protect the fetus from harm in the setting of maternal COVID-19 infection?
Lower placental ACE2 protein levels observed in cases of third trimester maternal COVID-19 infection may be...
Expert Commentary
Is the United States addressing maternal mortality rates from preeclampsia/eclampsia and chronic hypertension?
Racial disparities, advancing maternal age, and obesity all contributed to the increase in the annual maternal death rate...
Gynecologic Oncology Consult
Optimizing ‘optimal’ in ovarian cancer cytoreduction
While pafolacianine promises to move us closer to a true “R0” (negative margins) resection of ovarian cancer, is this even a feasible goal in a...